健脾理气法治疗原发性肝癌化疗栓塞术后综合征的疗效观察

Effective observation on treating chemoembolization syndrome of primary liver cancer by Jianpi Liqi therapy

目的:观察健脾理气法治疗原发性肝癌患者经导管动脉内化疗栓塞术后综合征的临床疗效。方法:将63例原发性肝癌患者随机分为两组,治疗组32例,对照组31例。治疗组术后第2d开始服用健脾理气的中药煎剂,对照组术后给予现代医学对症治疗。观察两组患者化疗栓塞术后综合征的症状持续时间、肝功能、Karnofsky评分情况等。结果:治疗组患者介入治疗后发热、肝区疼痛、恶心、呕吐、肝功能评分情况与对照组比较,差异均有显著性意义(P<0.05)。结论:健脾理气法对减轻肝癌化疗栓塞术后综合征,有较好的临床疗效。

Objective： To observe the clinical efficacy of Jianpi Liqi therapy on chemoembolization syndrome in liver cancer patients. Methods：63 primary liver cancer patients were randomly divided into two groups, 31 cases in the treatment group, 32 patients in the control group. Treatment group after the first two days to start taking the decoction, the control group was given symptomatic treatment. 2 set of symptoms observed in patients with postoperative chemotherapy and embolization syndrome duration, liver function, Karnofsky score and so on. Results：The treatment group after intervention fever, liver pain, nausea, vomiting, liver function, scoring situation were compared with control group, the difference was statistically significant （P〈0.05）. Conclusion：Jianpi Liqi therapy can reduce liver cancer chemoembolization syndrome.